Myelosuppression
Shigeoka, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 147-152
2012
ISSN/ISBN: 0047-1852 PMID: 23156500 Document Number: 657353
Document emailed within 1 workday
Related Documents
Lagneaux, L.; Delforge, A.; Stryckmans, P.; Bron, D. 1993: Cytomegalovirus-mediated myelosuppression Experimental Hematology 21(7): 837-838Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
Abena, P.A.; Mathieux, V.G.; Scheiff, J.M.; Michaux, L.M.; Vandercam, B.C. 2001: Linezolid and reversible myelosuppression JAMA 286(16): 1973; Author Reply 1974
Alberts, D.S. 1999: Protection by amifostine of cyclophosphamide-induced myelosuppression Seminars in Oncology 26(2 Suppl 7: 37-40
Charak, B.S. 1991: Amelioration of high dose cyclophosphamide-induced myelosuppression National Medical Journal of India 4(1): 30
Khoo, K.S.; Ang, P.T. 1995: Extract of astragalus membranaceus and ligustrum lucidum does not prevent cyclophosphamide-induced myelosuppression Singapore Medical Journal 36(4): 387-390
Ogilvie, G.K.; Elmslie, R.E.; Cecchini, M.; Walters, L.M.; Pearson, F.C. 1992: Use of a biological extract of Serratia marcescens to decrease doxorubicin-induced myelosuppression in dogs American Journal of Veterinary Research 53(10): 1787-1790
Shevchuk, O.O.; Posokhova, К.А.; Todor, I.N.; Lukianova, N.Yu.; Nikolaev, V.G.; Chekhun, V.F. 2015: Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factor Experimental Oncology 37(2): 135-138
Dygaĭ, A.M.; Zhdanov, V.V.; Minakova, M.I.; Ryzhakov, V.M.; Gol'dberg, E.D. 1997: The role of proliferation and differentiation of the hematopoietic cell precursors during regeneration of hematopoiesis in cytostatic myelosuppression Biulleten' Eksperimental'noi Biologii i Meditsiny 124(12): 616-620
Suzuki, H.; Sasada, S.; Matsuda, Y.; Otani, Y.; Morishita, N.; Kobayashi, M.; Okamoto, N.; Hirashima, T.; Matsui, K.; Kawase, I. 2008: Two cases of severe myelosuppression from amrubicin in previously-treated small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(3): 491-493
Kovacs, C.J.; Kerr, J.A.; Daly, B.M.; Evans, M.J.; Johnke, R.M. 1998: Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression Anticancer Research 18(3a): 1805-1812